179 related articles for article (PubMed ID: 10716933)
1. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice.
Onodera K; Shavit JA; Motohashi H; Yamamoto M; Engel JD
EMBO J; 2000 Mar; 19(6):1335-45. PubMed ID: 10716933
[TBL] [Abstract][Full Text] [Related]
2. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice.
Shavit JA; Motohashi H; Onodera K; Akasaka J; Yamamoto M; Engel JD
Genes Dev; 1998 Jul; 12(14):2164-74. PubMed ID: 9679061
[TBL] [Abstract][Full Text] [Related]
3. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response.
Katsuoka F; Motohashi H; Tamagawa Y; Kure S; Igarashi K; Engel JD; Yamamoto M
Mol Cell Biol; 2003 Feb; 23(4):1163-74. PubMed ID: 12556477
[TBL] [Abstract][Full Text] [Related]
4. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins.
Motohashi H; Katsuoka F; Shavit JA; Engel JD; Yamamoto M
Cell; 2000 Dec; 103(6):865-75. PubMed ID: 11136972
[TBL] [Abstract][Full Text] [Related]
5. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes.
Katsuoka F; Motohashi H; Ishii T; Aburatani H; Engel JD; Yamamoto M
Mol Cell Biol; 2005 Sep; 25(18):8044-51. PubMed ID: 16135796
[TBL] [Abstract][Full Text] [Related]
6. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
Toki T; Itoh J; Kitazawa J; Arai K; Hatakeyama K; Akasaka J; Igarashi K; Nomura N; Yokoyama M; Yamamoto M; Ito E
Oncogene; 1997 Apr; 14(16):1901-10. PubMed ID: 9150357
[TBL] [Abstract][Full Text] [Related]
7. Compound mouse mutants of bZIP transcription factors Mafg and Mafk reveal a regulatory network of non-crystallin genes associated with cataract.
Agrawal SA; Anand D; Siddam AD; Kakrana A; Dash S; Scheiblin DA; Dang CA; Terrell AM; Waters SM; Singh A; Motohashi H; Yamamoto M; Lachke SA
Hum Genet; 2015 Jul; 134(7):717-35. PubMed ID: 25896808
[TBL] [Abstract][Full Text] [Related]
8. Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators.
Moran JA; Dahl EL; Mulcahy RT
Biochem J; 2002 Jan; 361(Pt 2):371-7. PubMed ID: 11772409
[TBL] [Abstract][Full Text] [Related]
9. Structure and chromosome mapping of the human small maf-genes MAFG and MAFK.
Iwata T; Kogame K; Toki T; Yokoyama M; Yamamoto M; Ito E
Cytogenet Cell Genet; 1998; 82(1-2):88-90. PubMed ID: 9763667
[TBL] [Abstract][Full Text] [Related]
10. Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins.
Yamazaki H; Katsuoka F; Motohashi H; Engel JD; Yamamoto M
Mol Cell Biol; 2012 Feb; 32(4):808-16. PubMed ID: 22158967
[TBL] [Abstract][Full Text] [Related]
11. The world according to Maf.
Motohashi H; Shavit JA; Igarashi K; Yamamoto M; Engel JD
Nucleic Acids Res; 1997 Aug; 25(15):2953-59. PubMed ID: 9224592
[TBL] [Abstract][Full Text] [Related]
12. Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression.
Blank V; Kim MJ; Andrews NC
Blood; 1997 Jun; 89(11):3925-35. PubMed ID: 9166829
[TBL] [Abstract][Full Text] [Related]
13. Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene.
Dhakshinamoorthy S; Jaiswal AK
J Biol Chem; 2000 Dec; 275(51):40134-41. PubMed ID: 11013233
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants for small Maf protein control of platelet production.
Motohashi H; Fujita R; Takayama M; Inoue A; Katsuoka F; Bresnick EH; Yamamoto M
Mol Cell Biol; 2011 Jan; 31(1):151-62. PubMed ID: 20974807
[TBL] [Abstract][Full Text] [Related]
15. Small Maf proteins (MafF, MafG, MafK): History, structure and function.
Katsuoka F; Yamamoto M
Gene; 2016 Jul; 586(2):197-205. PubMed ID: 27058431
[TBL] [Abstract][Full Text] [Related]
16. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction.
Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Aug; 21(34):5301-12. PubMed ID: 12149651
[TBL] [Abstract][Full Text] [Related]
17. One enhancer mediates mafK transcriptional activation in both hematopoietic and cardiac muscle cells.
Katsuoka F; Motohashi H; Onodera K; Suwabe N; Engel JD; Yamamoto M
EMBO J; 2000 Jun; 19(12):2980-91. PubMed ID: 10856242
[TBL] [Abstract][Full Text] [Related]
18. Ablation of Nrf2 function does not increase the erythroid or megakaryocytic cell lineage dysfunction caused by p45 NF-E2 gene disruption.
Kuroha T; Takahashi S; Komeno T; Itoh K; Nagasawa T; Yamamoto M
J Biochem; 1998 Mar; 123(3):376-9. PubMed ID: 9538217
[TBL] [Abstract][Full Text] [Related]
19. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway.
Motohashi H; Katsuoka F; Engel JD; Yamamoto M
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6379-84. PubMed ID: 15087497
[TBL] [Abstract][Full Text] [Related]
20. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors.
Motohashi H; O'Connor T; Katsuoka F; Engel JD; Yamamoto M
Gene; 2002 Jul; 294(1-2):1-12. PubMed ID: 12234662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
